SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) November 3, 2003
MACROPORE BIOSURGERY, INC.
(Exact name of registrant as specified in Charter)
Delaware |
| 000-32501 |
| 33-0827593 |
(State or Other Jurisdiction |
| (Commission File |
| (IRS Employer |
6740 Top Gun Street, San Diego, California |
| 92121 |
(Address of Principal Executive Offices) |
| (Zip Code) |
Registrant’s telephone number, including area code: | (858) 458-0900 |
Item 7: Financial Statements and Exhibits.
(c) Exhibits
99.1 Press Release of MacroPore Biosurgery, Inc. dated November 3, 2003
Item 12: Results of Operations and Financial Conditions.
On November 3, 2003, MacroPore Biosurgery, Inc. issued a press release with respect to their financial results for the third quarter of 2003. This press release is attached as exhibit 99.1 and is incorporated herein by reference.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| MACROPORE BIOSURGERY, INC. | ||
|
| ||
|
| ||
Dated: November 3, 2003 | By: | /s/ | Christopher J. Calhoun |
|
|
| Christopher J. Calhoun |
|
|
| President and Chief Executive Officer |
2